NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/21/2026
Back to search
Official data from USPTO
VVVVVVVV VEDA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
07/21/2026
Trademark type
Combined
Nice classes
42
Filing date
02/27/2024
Registration date
07/21/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/21/2026
Last transaction
07/21/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2024-07-00
First use in commerce
2024-07-00
Drawing code
3
Owner type
03
Owner location
Frederick, MD, US
Examiner
DETMER, CAROLYN ROSE
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized drawing of a starburst wherein the border is comprised of eight stylized "V" letters, the the left of the stylized word "VEDA".
Holders and representatives
Holders
Veda Life Sciences, Inc.
Representatives
Elizabeth Oliner Crandon Law
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Platform as a service (PAAS) featuring computer software platforms for use in providing back-end automation features to assist in onboarding new clinical trial sites and healthcare providers for facilitating and enabling recruitment of participants for use in runningmanaging and analyzing clinical trialsnamely enabling providers to create and scale clinical research capabilities and bring scientific advancements to patients that need them most; Platform as a service (PAAS) featuring computer software platforms for management and/or participation in clinical research in the nature of database creation and selecting configurable data collection methods with configurable optionsconfiguring a participant- facing website to recruit and screen participants for eligibility; Platform as a service (PAAS) featuring computer software platforms for automating workflows around patient communicationdata entryregulatory management and clinical trial operations use in facilitating and managing compliance and enabling preparation of new study trial sites for use in bringing trained clinical research coordinators together with community managers to run clinical trials at scale; Providing a website featuring online non-downloadable software for engaging community based healthcare organizations and clinical trial sponsors for use in clinical research analyticsdata capture formsmanagementviewing data analyticsenabling site data capture; selecting configurable data collection methods with configurable optionsconfiguring a participant- facing website to recruit and screen participants for eligibility; Platform as a service (PAAS) featuring computer software platforms for automating workflows around patient communicationdata entryregulatory management and clinical trial operations use in facilitating and managing compliance and enabling preparation of new study trial sites for use in bringing trained clinical research coordinators together with community managers to run clinical trials at scale; Providing a website featuring online non-downloadable software for engaging community- based healthcare organizations and clinical trial sponsors for use in clinical research analyticsdata capture formselectronic clinical outcome assessmentrecruitmentelectronic consent; Providing information in the field of clinical research via a website; Providing scientific research information in the field of clinical trials; Consulting services for others in the field of designplanningimplementation project management of clinical trials; none of the foregoing comprised of or consisting of the provision of healthcare or telehealth servicesscheduling healthcare or telehealth appointmentsallowing a patient to access personal healthcare information for the provision of healthcare or telehealth services
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/21/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/30/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/30/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/08/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/07/2026
IUAF
USE AMENDMENT FILED
02/18/2026
EISU
TEAS STATEMENT OF USE RECEIVED
02/18/2026
CHPB
POST PUBLICATION AMENDMENT - ENTERED
01/21/2026
APET
ASSIGNED TO PETITION STAFF
01/13/2026
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/30/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
11/13/2025
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
11/08/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
05/28/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/06/2025
PUBO
PUBLISHED FOR OPPOSITION
05/06/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/30/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/29/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/29/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/29/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/24/2025
GNFR
FINAL REFUSAL E-MAILED
02/24/2025
CNFR
FINAL REFUSAL WRITTEN
02/24/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/19/2024
GNRT
NON-FINAL ACTION E-MAILED
09/19/2024
CNRT
NON-FINAL ACTION WRITTEN
09/19/2024
DOCK
ASSIGNED TO EXAMINER
09/16/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/08/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/08/2024
NWAP
NEW APPLICATION ENTERED
02/27/2024
Continuous trademark protection
Get notified about every new filing that threatens VVVVVVVV VEDA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.